Navigation Links
FDA May Ease Up on Electroshock Devices
Date:1/27/2011

THURSDAY, Jan. 27 (HealthDay News) -- Electroshock devices, currently classified by the U.S. Food and Drug Administration as high risk for the treatment of severe depression, could be downgraded to medium risk this year.

An FDA advisory panel is scheduled to meet Thursday to discuss reclassifying the devices, which would pave the way for wider use among people with depression and other mental illnesses.

A medium-risk classification would put the devices in the same category as syringes and allow them to be sold without new testing, The New York Times reported.

If the current classification continues, the FDA could require manufacturers to demonstrate that the devices are safe and effective, which it has not previously done. Some say the tests that such proof would require would be prohibitively expensive for the device makers.

The American Psychiatric Association supports the classification change, while opponents argue that electroshock therapy can cause long-term brain damage, including memory loss, the newspaper said.

"It's a treatment for the most severe form of depression," Dr. Charles Kellner, chief of geriatric psychiatry at Mount Sinai School of Medicine in New York City, told the Times. "It can really be lifesaving."

Dr. Edmi Y. Cortes, director of psychiatric services at the University of Miami Hospital, said that today's electroconvulsive therapy (ECT) devices are both safe and effective. "It's beneficial that some of the leading experts in psychiatry and ECT are getting together with the FDA to finalize a consensus," she said.

"The devices are effective when used appropriately," Cortes said. "For the most part, they are used to treat severe cases of depression, depression that has not been responsive to medication or depression that presents with symptoms like severe agitation or suicidal thoughts."

This type of depression is fairly uncommon, Cortes said. "For
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. SDI Reports: Nearly a Third Of Physicians Use Handheld and Smartphone Devices to Access Medical Information - Physicians Most Likely to be Using Apple iPhone
2. damaka Launches Live Video Streaming on Android and Blackberry Devices
3. Eisner USA, LLC Collaborates with Surgical Review Corp to Provide Innovative Bariatric Devices to Bariatric Surgery Center of Excellence (BSCOE) Participants
4. Rhausler Announces Record Growth of Nearly 700% for its Spinal Implant Devices
5. Damaka Delivers Advanced Sweeping™ Capability of Live Sessions Across Multiple Devices Over WiFi, 3G and 4G Networks
6. FDA Tightens Oversight of Home Medical Devices
7. Data Devices International Secures Exclusive Worldwide Distribution of the Erase-O-Matic Digital Video and Computer Tape Eraser
8. Vital functions monitored with wearable and implantable devices
9. Medical Devices Driving Up Heart Care Costs
10. Intrauterine devices reduce repeat abortions
11. Molecular Devices Relaunches with HiveMind Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... Security Life Insurance Company of ... announced the addition of stand-alone individual vision insurance ... launched today, complete with two plan options. , ... VSP® Vision Care network encompassing a strong presence ... The PrimeStar Select Vision plan will use the ...
(Date:3/1/2015)... is pleased to announce the addition of a digital library ... over 75 terms and phrases available for viewing, with more being ... a better understanding of what our Providers are talking about when ... this resource, our patients are able to go back to the ... they may not remember or comprehend at the time of their ...
(Date:3/1/2015)... Angeles, CA (PRWEB) March 01, 2015 ... now be possible when using the Quotes Pros portal ... available including United auto insurance rates that are being ... Access to the updated agencies and prices available for ... consumer's zip code online. Every system user will first ...
(Date:3/1/2015)... March 01, 2015 Researchers say working ... so many sheet metal workers contract malignant mesothelioma. Surviving ... report on its website. Click here to read ... Construction Research and Training monitored 17,345 sheet metal workers ... number of them died of mesothelioma or another ...
(Date:3/1/2015)... IL (PRWEB) March 01, 2015 Ticket Down ... Dead in Chicago at Soldier Field. Deadheads have ... announced in January. , Grateful Dead was formed 50 years ... they were together as one until the untimely death of ... for combining different genres including blues, reggae, rock, bluegrass, folk, ...
Breaking Medicine News(10 mins):Health News:Security Life Insurance Company Launches Individual Vision Insurance Product 2Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:New Study Finds Indirect Asbestos Exposure Can Raise Mesothelioma Risk for Sheet Metal Workers, According to Surviving Mesothelioma 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2
... April 27 The Jewish Home has named Nitin ... behavioral health. Dr. Nanda will also serve as medical ... Center at the Home,s Joyce Eisenberg-Keefer Medical Center on ... to these positions, Dr. Nanda will be responsible for ...
... 27, 2009) In recognition of their distinguished contributions ... Harbor-UCLA Medical Center (LA BioMed) will honor four of ... celebration May 12 at Trump National Golf Club. , ... J. Shapiro, MD, and Mark A. Sperling, MD, will ...
... individualized, men should get baseline reading at age 40LINTHICUM, ... Association (AUA) today issued new clinical guidance - which ... - about prostate cancer screening, asserting that the ... men aged 40 years or older who have a ...
... April 27 Tadalafil may improve lower urinary tract ... from Nashville, Dallas, San Antonio and Indianapolis will present ... the American Urological Association (AUA). In this study, researchers ... or older than 40 years and at least a ...
... educators and researchers free lecture notes and course notes, has ... of university level course materials on the internet. It includes ... site also allows registered users to post open courseware that ... with the world. , ...
... Inc., the industry leader in portable blood and IV ... Angel sales and marketing efforts. The Thermal Angel reduces ... temperature and infection risk. The Thermal Angel is crucial ... hour refers to the first 60 minutes after the ...
Cached Medicine News:Health News:New Chief of Geriatric Psychiatry and Behavioral Health is Announced 2Health News:Four legendary LA BioMed physician-researchers honored 2Health News:Four legendary LA BioMed physician-researchers honored 3Health News:Four legendary LA BioMed physician-researchers honored 4Health News:Four legendary LA BioMed physician-researchers honored 5Health News:AUA Counters Mainstream Recommendations with New Best Practice Statement on Prostate-Specific Antigen Testing 2Health News:AUA Counters Mainstream Recommendations with New Best Practice Statement on Prostate-Specific Antigen Testing 3Health News:AUA Counters Mainstream Recommendations with New Best Practice Statement on Prostate-Specific Antigen Testing 4Health News:Tadalafil May Effectively Treat Symptoms of BPH-LUTS in Addition to Erectile Dysfunction 2Health News:ShareCourseware.org - Free Lecture Notes and Course Notes Sharing Site Launched 2Health News:ShareCourseware.org - Free Lecture Notes and Course Notes Sharing Site Launched 3Health News:ShareCourseware.org - Free Lecture Notes and Course Notes Sharing Site Launched 4Health News:ShareCourseware.org - Free Lecture Notes and Course Notes Sharing Site Launched 5Health News:Thermal Angel Supports Infection Control During the Golden Hour 2
(Date:3/2/2015)... LEBANON, N.J. and BETHESDA, Md. ... clinical development-stage immunotherapy company focused on treating and preventing ... Phase 2-stage, anti-IL-15 monoclonal antibody (AMG 714) from Amgen ... this exclusive license agreement, Celimmune has the rights to ... basis excluding Japan . Concurrently, Amgen ...
(Date:3/2/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it ... 2014 on March 9, 2015. The Company also plans to hold ... 2015, at 5:00 pm ET. The call will be hosted by ... , , , LIVE CALL:  , , , (877) ... , , , , , , ...
(Date:3/1/2015)... , March 1, 2015  Patients suffering from ... against this debilitating foot ailment, according to research ... ,s Annual Scientific Meeting . Researchers utilized ... emulsify and remove diseased fasciitis tissue. Permanently removing ... to regrow in its place, restoring normal function. ...
Breaking Medicine Technology:Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3
... Neuradiab(TM) compares favorably to data from other, ... 17 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc.,(TSX: BMR), a ... cancer therapies, today released progression free,survival (PFS) data ... in glioblastoma multiforme (GBM) patients. As an exploratory,endpoint ...
... Conn., July 16 Biodel Inc. (Nasdaq:,BIOD) today announced ... now complete, with the last study patient visit on ... released either at Biodel,s poster,presentation at the European Association ... 2008, or at a later appropriate scientific forum., ...
Cached Medicine Technology:Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 3Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 4Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 5Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 2Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 3Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 4Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 5